Surgery Partners: Mizuho cuts to neutral from outperform; raises target price to $25 from $19
SGRY•Mizuho cut its rating on Surgery Partners to neutral from outperform and raised its target price to $25 from $19.
Related News
Nasdaq trade halt continues, reason not available at 03:58 a.m.
HCHL•
NY cocoa may slide into $4,315-$4,419 range
CC•
Equifax analysis shows liquid wealth drives consumer financial resilience
EFX•
Oil up 1% after Iran says no nuclear material will leave the country
USO•
ArcelorMittal's $900 million Brazil expansion plan trudges along as imports weigh on economics
MT•